Solesence, Inc. Common Stock (SLSN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Solesence, Inc. Common Stock (SLSN) has a cash flow conversion efficiency ratio of 0.103x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.82 Million) by net assets ($17.63 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Solesence, Inc. Common Stock to measure how many days the company can operate on defensive assets alone.
Solesence, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Solesence, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Solesence, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Solesence, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aroot Co. Ltd
KQ:096690
|
-0.026x |
|
Bridgemarq Real Estate Services Inc
TO:BRE
|
-0.044x |
|
LINMON MEDIA LTD -000025
F:8MN
|
N/A |
|
BCP Investment Corp.
NASDAQ:BCIC
|
0.112x |
|
Kyongbo Pharmaceutical Co Ltd
KO:214390
|
0.031x |
|
OncoCyte Corp
NASDAQ:OCX
|
-0.573x |
|
Micropolis Holding Company
NYSE MKT:MCRP
|
0.063x |
|
AptaBio Therapeutics Inc
KQ:293780
|
-0.061x |
Annual Cash Flow Conversion Efficiency for Solesence, Inc. Common Stock (2021–2025)
The table below shows the annual cash flow conversion efficiency of Solesence, Inc. Common Stock from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see SLSN company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $17.63 Million | $-8.57 Million | -0.486x | -468.40% |
| 2024-12-31 | $14.95 Million | $1.97 Million | 0.132x | +112.50% |
| 2023-12-31 | $1.90 Million | $-2.01 Million | -1.055x | -261.08% |
| 2022-12-31 | $5.65 Million | $-1.65 Million | -0.292x | -193.94% |
| 2021-12-31 | $7.46 Million | $2.32 Million | 0.311x | -- |
About Solesence, Inc. Common Stock
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingre… Read more